Skip to main content

Bausch + Lomb (US:BLCO) — Company Overview, News & Financial Data

Bausch + Lomb  logo
BLCOBausch + Lomb
Bausch + Lomb  primary media
Company profile

Bausch + Lomb

Bausch + Lomb (NYSE:BLCO) is a well-known company focused on eye health, engaging in a broad range of activities aimed at improving the sight and lives of people worldwide. Its operations span across the manufacture and sale of contact lenses, surgical instruments, eye care products, and pharmaceuticals dedicated to treating a variety of eye conditions. With a rich history of innovation, Bausch + Lomb is committed to advancing the field of vision care through the development of new technologies and treatments. The company's objectives are centered on enhancing patient care and leading the industry in sustainable practices. Through ongoing research and development projects, Bausch + Lomb strives to meet the evolving needs of both eye care professionals and patients, ensuring everyone has access to the best possible eye health solutions.

Snapshot

Public USOwnership
1853Year founded
8501Employees
Rochester, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
United States

Products and/or services of Bausch + Lomb

  • Contact lenses including soft, daily disposables, and extended wear options, providing vision correction and comfort.
  • Pharmaceuticals for eye conditions such as glaucoma, eye infections, and dry eye syndrome.
  • Surgical products including intraocular lenses and devices for cataract and retinal surgery.
  • Over-the-counter products like eye vitamins, drops for dry eyes, and lens care solutions.
  • Vision care products including contact lens care solutions, eye washes, and ocular vitamins for eye health maintenance.
  • Aesthetic devices for treatments like laser skin rejuvenation and hair removal.

Bausch + Lomb executive team

  • Mr. Brenton L. Saunders J.D.CEO & Chairman
  • Mr. Osama A. EldessoukyExecutive VP & CFO
  • Mr. A. Robert D. BaileyExecutive VP & Chief Legal Officer
  • Dr. Yehia Hashad M.D., Ph.D.Executive VP of Research & Development and Chief Medical officer
  • Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer
  • Mr. Alan Waterhouse CPFA, MBAExecutive VP and Chief Supply Chain & Operations Officer
  • Mr. Frederick J. MunschSenior VP, Controller & Chief Accounting Officer
  • Mr. George GadkowskiVP & Head of Investor Relations & Business Insights
  • Mr. Jonathon L. KellermanChief Compliance Officer
  • Mr. T.J. CrawfordChief Communications Officer